HHS Stock Analysis: Buy, Sell, or Hold?
$3.97
0.00 (0.00%)
▲
5d:
-0.75%
30d:
-10.59%
90d:
+75.66%
BUY
HIGH Confidence
Analysis Updated: Nov 4, 2026 12:00 AM ET
Earnings: Nov 09, 2026
3d
Get Alerted When HHS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: HHS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: HHS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$4.35
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$2.70
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 2.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HHS is currently trading at $3.97, which is considered slightly low relative to its 30-day fair value range of $3.96 to $4.51. From a valuation perspective, the stock is trading at a premium (Forward PE: 3.7) compared to its historical average (2.9). At these levels, the market is pricing in 8.3% annual earnings growth.
Technical Outlook: Technically, HHS is in a strong uptrend. The price is approaching resistance at $4.07. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: HHS scores 77/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $17.50 (+340.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, HHS is in a strong uptrend. The price is approaching resistance at $4.07. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: HHS scores 77/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $17.50 (+340.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$3.96 -
$4.51
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
93.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (77/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 340.8% below Wall St target ($17.50)
- BULLISH: Expecting earnings turnaround to 8.3% growth with -1.7% revenue growth
- BULLISH: Bottoming setup score 77/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$3.96 -
$4.51
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$3.45
Resistance Level
$4.07
Current Trend
Strong Uptrend
Technical data as of
Nov 4, 2026
Fundamental Context
Forward P/E (Next Year Est.)
3.71
Wall Street Target
$17.50
(+340.8%)
Revenue Growth (YoY)
-1.7%
Earnings Growth (YoY)
-90.3%
Profit Margin
-3.7%
Valuation Premium vs History
+8.3% premium
PE vs Historical
3.7 vs 2.9
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+8.3%
(market-implied from PE analysis)
1-Year Target
$4.30
(+8%)
2-Year Target
$4.66
(+17%)
3-Year Target
$5.04
(+27%)
3-Yr Target (if PE normalizes)
(PE: 4→3)
PE COMPRESSION
$3.94
(-1%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: November 05, 2026 1:57 AM ET
Data refreshes hourly during market hours. Next update: 2:57 AM
Data refreshes hourly during market hours. Next update: 2:57 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HHS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Conglomerates Stocks
Top-rated stocks in Conglomerates by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HON
Honeywell International … |
BUY
24 analysts |
$254 | 41 HOLD |
|
MMM
3M Company |
HOLD
19 analysts |
$190 | 38 SELL |
|
PAM
Pampa Energia SA ADR |
STRONG BUY
11 analysts |
$123 | 36 SELL |
|
VMI
Valmont Industries Inc |
STRONG BUY
5 analysts |
$611 | 45 HOLD |
|
BBU
Brookfield Business Part… |
STRONG BUY
6 analysts |
$41 | 52 HOLD |